Data / Form D filings / EIP Pharma, Inc.
EIP Pharma, Inc.: Form D filings
EIP Pharma, Inc., a biotechnology company in Boston, MA, filed 6 Form D notices with the SEC between 2018 and 2023. The latest, on July 20, 2023, reports $810,000 sold of a $810,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 PARK PLAZA, SUITE 424, Boston, MA, 02116
- Phone
- (617) 744-4400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1736525
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 20, 2023 | New notice | $810,000 | $810,000 | 2 | Jul 10, 2023 | sec.gov | |
| Dec 23, 2021 | New notice | $10,000,000 | $6,000,000 | $4,000,000 | 3 | Dec 10, 2021 | sec.gov |
| Jan 15, 2021 | New notice | $10,000,000 | $5,078,500 | $4,921,500 | 28 | Dec 4, 2020 | sec.gov |
| Jan 23, 2020 | New notice | $4,500,000 | $2,730,000 | $1,770,000 | 6 | Jan 9, 2020 | sec.gov |
| Dec 19, 2018 | New notice | $12,500,000 | $9,000,000 | $3,500,000 | 4 | Dec 12, 2018 | sec.gov |
| Apr 13, 2018 | New notice | $20,499,999 | $20,499,999 | 3 | Apr 2, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JEFF POULTON | Director | |
| WILLIAM TURNER | Executive Officer | |
| SYLVIE GREGOIRE | Director | |
| FRANK ZAVRL | Director | |
| KELLY BLACKBURN | Executive Officer | |
| JOHN ALAM | Executive Officer, Director | |
| MARWAN SABBAGH | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 17, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EIP Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.